BMT Pharmacists Conference

THURSDAY – FEBRUARY 14

7:00 am - 6:00 pm
Registration

FRIDAY – FEBRUARY 15

7:00 am
Registration 

8:30 am
Welcome and Overview 
Helen Leather, BPharm, BCPS, University of Florida, Conference Chair
Tracey Walsh-Chocolaad, PharmD, BCOP, Oncology Consultant, Conference Co-Chair

8:35 am
American Society of Hematology (ASH) Meeting Rehash – Part I
Malignant Hematology
Juliana Burzynski, PharmD, Mayo Clinic, Rochester, Minn.

9:25 am
Transplantation or Standard Chemotherapy in Multiple Myeloma – What Is the Right Approach in 2008?
Morie A. Gertz, MD, Mayo Clinic Rochester, Md
David H. Vesole, MD, PhD, and Morie A. Gertz, MD

10:30 am
Controversies in Lymphoma Therapy
 ■ Diffuse Large Cell Lymphoma:  Gene Expression Profiling and Prognosis
     Izidore S. Lossos, MD, University of Miami, Miami, Fla.
 ■ Hematopoietic Cell Transplantation for T-Cell Non-Hodgkin Lymphoma:  Does it Work?
     Ginna G. Laport, MD, Stanford University Medical Center, Stanford, Calif.
 ■ Mantle Cell Lymphoma in First Remission:  What Next?
     Peter Dreger, MD, PhD, University of Heidelberg, Heidelberg, Germany  

Noon
Lunch Break

1:40 pm
Therapeutic Drug Monitoring of Azoles in Invasive Aspergillosis Is Associated with Better Outcomes - Point/Counterpoint
     James S. Lewis, PharmD, University of Texas Heath Science Center, San Antonio, Texas, 
    and Melissa Johnson, PharmD, BCPS, Duke University Medical Center, Raleigh, N.C.

2:45 pm
Best Pharmacist Abstracts Session

3:45 pm
American Society of Hematology (ASH) Meeting Rehash – Part II
Hematolopoietic Stem Cell Transplantatin Issues
Robert Wolf, PharmD, Mayo Clinic, Rochester MN

4:30 pm
Adjourn

SATURDAY – FEBRUARY 16

8:30 am
Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) Rehash
James S. Lewis

9:20 am
Relapse Post Transplant – Management Strategies
Sergio Giralt, MD, M.D. Anderson Cancer Center, Houston, Texas

10:30 am
BMT CTN 0101:  Fluconazole vs. Voriconazole Prophylaxis Study – the Complete Analysis
John R. Wingard, MD, University of Florida, Gainesville

11:20 am
Infectious Disease Society of America Candidiasis and Aspergillus Guidelines:  An Update 
Melissa Johnson

12:10 pm
Lunch Break
 
1:30 pm
Reimmunization Post-Transplant:  Who, When What With?
Sussannah Koontz, PharmD, M.D. Anderson Cancer Center, Houston, Texas

2:50 pm
Stem Cell Mobilization:  An Update
Steven M. Devine, MD, Ohio State University, Columbus, Ohio

3:40 pm
Clinical Controversies
 ■ Chemotherapy Preparative Regimens in Patients with Renal Impairment
      Joseph Bubalo, PharmD, BCPS, BCOP, Oregon Heath Science Center, Portland, Ore.
 ■ Management of HUS/TTP
      Laura Wiggins, Shands HealthCare, University of Florida, Gainesville, Fla.

4:50 pm
Adjourn

SUNDAY – FEBRUARY 17

8:30 am
Transplants for Acute Leukemia
 ■ Pediatric Acute Leukemia
      Stella M. Davies, MD, PhD, Cincinnati Children's Hospital, Cincinnati, Ohio
 ■ Adult Acute Lymphoblastic Leukemia
      Jacob M. Rowe, MD, Rambam Medical Center, Haifa, Israel
 ■ Adult Acute Myeloid Leukemia
      Frederick R. Appelbaum, MD, Fred Hutchinson Cancer Research Center, Seattle, Wash.

10:00 am
Adjourn